---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-003842"
form_type: "8-K"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2026-01-28T23:59:59+00:00"
generated_at: "2026-05-16T07:04:02.549500+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Amneal Pharmaceuticals makes effective opioid settlement with states and subdivisions

## Summary
- Amneal determined to make effective its Nationwide Opioids Settlement Agreement on Jan 29, 2026, with sufficient state and subdivision participation.
- Company will pay $88.5 million to participating states and subdivisions.
- Company will provide up to $177.4 million in naloxone nasal spray (valued at $125 per twin pack) to treat opioid overdoses.
- Settling parties can opt for cash up to $44.4 million (25% of product value) during last four years of ten-year term, potentially raising total cash to $132.9 million.

## SEC filing metadata
- accession: 0001628280-26-003842
- form_type: 8-K
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2026-01-28T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000162828026003842/0001628280-26-003842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000162828026003842/amrx-20260123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-003842
- JSON: https://secwatch.observer/filing/0001628280-26-003842.json
- Plain text: https://secwatch.observer/filing/0001628280-26-003842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.